Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
fda
life sciences
national
7
×
national blog main
national top stories
clinical trials
san francisco top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
biogen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
europe blog main
europe top stories
gene therapy
genentech
indiana blog main
indiana top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
allergan
amgen
cancer
eli lilly
What
fda
7
×
new
approved
bio
drug
medicine
medicines
patients
roundup
therapy
activity
adults
allergan
approvals
atrophy
august
biogen
biotech
busy
cancer
cash
chemistry
clamped
class
clearance
cmc
company
consistent
controls
covid
crunch
daily
days
decisions
delays
developing
devices
didn’t
drugs
economic
Language
unset
7
×
Current search:
national
×
unset
×
fda
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More